Expression of genes modulated by epigallocatechin-3-gallate in breast cancer cells

1. Radecka B, Litwiniuk M. Breast cancer in young women. Ginekol Pol 2016; 87(9):659-663. doi: http://dx.doi.org/10.5603/GP.2016.006210.5603/GP.2016.006227723074Ouvrir le DOISearch in Google Scholar

2. Siegel R, Jiemin MA, Zhaohui Z, Jemal A. Cancer statistics. Cancer J Clin 2014; 64(1):9-29. doi: http://dx.doi.org/10.3322/caac.2120810.3322/caac.2120824399786Ouvrir le DOISearch in Google Scholar

3. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003; 78:517S–520S. doi: http://dx.doi.org/10.1093/ajcn/78.3.517S10.1093/ajcn/78.3.517S12936943Ouvrir le DOISearch in Google Scholar

4. Liu RH. Whole grain phytochemicals and health. J Cereal Sci 2007; 46(3):207-219.10.1016/j.jcs.2007.06.010Ouvrir le DOISearch in Google Scholar

5. Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr 2013; 4(3):384S–392S. doi: http://dx.doi.org/10.3945/an.112.00351710.3945/.112.003517Ouvrir le DOISearch in Google Scholar

6. Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer 2009; 62(1):1-20. doi: http://dx.doi.org/10.1080/0163558090319158510.1080/0163558090319158520043255Ouvrir le DOISearch in Google Scholar

7. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13(8):353-361. doi: http://dx.doi.org/10.1016/j.molmed.2007.07.00110.1016/j.molmed.2007.07.00117644431Ouvrir le DOISearch in Google Scholar

8. Tapas A, Sakarkar D, Kakde R. Flavonoids as nutraceuticals: A review. Herba Pol 2010; 56(2):105-117.Search in Google Scholar

9. Ramos S. Cancer chemoprevention and chemo-therapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008; 52(5):507-526. doi: http://dx.doi.org/10.1002/mnfr.20070032610.1002/mnfr.20070032618435439Ouvrir le DOISearch in Google Scholar

10. Sen T, Dutta A, Chatterjee A. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs 2010; 21(6):632-644.10.1097/CAD.0b013e32833a438520527725Search in Google Scholar

11. Stefaniak A, Sytykiewicz H, Czerniewicz P, Leszczyński B. Catechin-like antioxidative potential of selected tea products. Herba Pol 2012; 58(2):17-25.Search in Google Scholar

12. Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate. Eur J Pharma Sci 2010; 41(2):219-225. doi: http://dx.doi.org/10.1016/j.ejps.2010.06.01010.1016/j.ejps.2010.06.01020600878Ouvrir le DOISearch in Google Scholar

13. Stuart EC, Scandlyn MJ, Rosengren RJ. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci 2006; 79(25):2329-2336. doi: http://dx.doi.org/10.1016/j.lfs.2006.07.03610.1016/j.lfs.2006.07.036Ouvrir le DOISearch in Google Scholar

14. Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci 2011; 12 (9):5592-5603.10.3390/ijms12095592Ouvrir le DOISearch in Google Scholar

15. Klinski E, Semov A, Yan X, Alakhov V., Muyzhnek E., Kiselev V. Block copolymer-based composition of epigallocatechin-3-gallate with improved oral bioavailability as a way to increase its therapeutic activity. J Nanomedicine Bio-therapeutic Disc 2013; 3:117. doi: http://dx.doi.org/10.4172/2155-983X.100011710.4172/2155-983X.1000117Ouvrir le DOISearch in Google Scholar

16. Luo H, Xu M, Zhong WT, Cui ZY, Liu FM, Zhou KY et al. EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells. J BUON. 2013; 19 (2): 435-439.Search in Google Scholar

17. Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF et al. A component of green tea, (−)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 2007; 354(4):852-857. doi: http://dx.doi.org/10.1016/j.bbrc.2007.01.00310.1016/j.bbrc.2007.01.003Ouvrir le DOISearch in Google Scholar

18. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)-epigallocatechin-3-gallate. J Cell Biochem. 1999; 75 (1): 1-12.10.1002/(SICI)1097-4644(19991001)75:1<1::AID-JCB1>3.0.CO;2-NOuvrir le DOISearch in Google Scholar

19. Sun L, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006; 27(7):1310-1315. doi: http://dx.doi.org/10.1093/carcin/bgi27610.1093/carcin/bgi276Ouvrir le DOISearch in Google Scholar

20. Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 2010; 119:477-484. doi: http://dx.doi.org/10.1007/s10549-009-0415-010.1007/s10549-009-0415-0Ouvrir le DOISearch in Google Scholar

21. Thangapazham RT, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007; 245(1-2):232-241. doi: http://dx.doi.org/10.1016/j.canlet.2006.01.02710.1016/j.canlet.2006.01.027Ouvrir le DOISearch in Google Scholar

22. Tran PL, Kim SA, Choi HS, Yoon JH, Ahn SG. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer 2010; 10:276. doi: http://dx.doi.org/10.1186/1471-2407-10-27610.1186/1471-2407-10-276Search in Google Scholar

23. Manjegowda MC, Deb G, Kumar N, Limaye AM. Expression profiling of genes modulated by estrogen, EGCG or both in MCF-7 breast cancer cells. Genomics Data 2015; 5:210-212. doi:http://dx.doi.org/10.1016/j.gdata.2015.05.04010.1016/j.gdata.2015.05.040Ouvrir le DOISearch in Google Scholar

24. Bronsert P, Kohler I, Timme S, Kiefer S, Werner M, Schilling O et al. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer. Surgery 2014; 156(1):97-108. doi: http://dx.doi.org/10.1016/j.surg.2014.02.01810.1016/j.surg.2014.02.01824929761Ouvrir le DOISearch in Google Scholar

25. Karihtala P, Auvinen P, Kauppila S, Haapasaari KM, Jukkola-Vuorinen A, Soini Y. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype. Breast Cancer Res Treat 2013; 138(1):81-90. doi: http://dx.doi.org/10.1007/s10549-013-2442-010.1007/s10549-013-2442-023412770Ouvrir le DOISearch in Google Scholar

26. Liu Y, Lu X, Huang L, Wang W, Jiang G, Dean KC et al. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nat Commun 2014; 5:5660. doi: http://dx.doi.org/10.1038/ncomms666010.1038/ncomms666025434817Ouvrir le DOISearch in Google Scholar

27. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011; 30 (4):770-782. doi: http://dx.doi.org/10.1038/emboj.2010.34910.1038/emboj.2010.349304194821224848Ouvrir le DOISearch in Google Scholar

28. Zhu Z, Wang Y, Liu Z, Wang F, Zhao Q. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in human pancreatic carcinoma cell line PANC-1. Oncol Rep 2012; 27(5):1567-1572. doi: http://dx.doi.org/10.3892/or.2012.169710.3892/or.2012.169722367292Ouvrir le DOISearch in Google Scholar

29. Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 2010; 17(1):86-92. doi: http://dx.doi.org/10.1038/cdd.2009.7710.1038/cdd.2009.77369048719543236Ouvrir le DOISearch in Google Scholar

30. Jin L, Li C, Xu Y, Wang L, Liu J, Wang D et al. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells. Oncol Rep. 2013; 29(5):1983-1990. doi: http://dx.doi.org/10.3892/or.2013.234310.3892/or.2013.234323483203Ouvrir le DOISearch in Google Scholar

31. Zhong J, Ogura K, Wang Z, Inuzuka H. Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov Med 2013; 15(80):7-15.Search in Google Scholar

32. Li Ch, Duan P, Wang J, Lu X, Cheng J. miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression. Am J Transl Res. 2017; 9(8): 3705-3713.Search in Google Scholar

33. De Amicis F, Perri A, Vizza D, Russo A, Panno ML, Bonofiglio D et al. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J Cell Physiol. 2013; 228(10):2054-2062. doi: http://dx.doi.org/10.1002/jcp.2437210.1002/jcp.2437223553645Search in Google Scholar

34. Liu S, Xu ZL, Sun L, Liu Y, Li CC, Li HM et al. (-)-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN. Mol Med Rep 2016; 14(1):599-605. doi: http://doi.org/10.3892/mmr.2016.527710.3892/mmr.2016.527727176210Ouvrir le DOISearch in Google Scholar

35. Moradzadeh M, Hosseini A, Erfanian S, Rezaei H. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. Pharmacol Rep 2017; 69(5):924-928. doi: http://dx.doi.org/10.1016/j.pharep.2017.04.00810.1016/j.pharep.2017.04.00828646740Ouvrir le DOISearch in Google Scholar

• Chemical profiles and biological activities of acetone extracts of Curcuma xanthella
• Geranyl flavanone from Feronia limonia (L.) Swingle
• Evaluation of detoxification of aflatoxin-b1 by using Ag nanoparticles of oil extracts user prepared by using some medical herbs
• Synthetic seeds technology of Salvia officinalis as a method for short-term storage and in vitro propagation of valuable genotypes
• Morphological and biochemical responses of selected Ocimum species under drought